Terry-Ann Burrell
Director of Finance/CFO at BEAM THERAPEUTICS INC.
Net worth: 3 M $ as of 2024-03-30
Profile
Presently, Terry-Ann Burrell holds the position of Chief Financial Officer & Treasurer of Beam Therapeutics, Inc. Ms. Burrell is also on the board of Recursion Pharmaceuticals, Inc. In her past career she occupied the position of Managing Director at JPMorgan Securities LLC. Ms. Burrell received an undergraduate degree from Harvard University and an MBA from The Leonard N Stern School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BEAM THERAPEUTICS, INC.
0.09% | 2024-03-31 | 70,137 ( 0.09% ) | 2 M $ | 2024-03-30 |
| 2024-03-31 | 56,314 ( 0.03% ) | 561 451 $ | 2024-03-30 |
Terry-Ann Burrell active positions
| Companies | Position | Start |
|---|---|---|
| BEAM THERAPEUTICS INC. | Director of Finance/CFO | 2019-07-31 |
| RECURSION PHARMACEUTICALS, INC. | Director/Board Member | 2020-03-31 |
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. is an American clinical-stage biotechnology company that focuses on discovering and developing medicines for neurological disorders. The CEO of the company is Abraham N. Ceesay. | Director/Board Member | 2024-01-15 |
Former positions of Terry-Ann Burrell
| Companies | Position | End |
|---|---|---|
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Corporate Officer/Principal | 2019-07-31 |
Training of Terry-Ann Burrell
| Harvard University | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| RECURSION PHARMACEUTICALS, INC. | Health Technology |
| BEAM THERAPEUTICS INC. | Health Technology |
| Private companies | 2 |
|---|---|
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Finance |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. is an American clinical-stage biotechnology company that focuses on discovering and developing medicines for neurological disorders. The CEO of the company is Abraham N. Ceesay. | Health Technology |
- Stock Market
- Insiders
- Terry-Ann Burrell
